FDA Drug Recalls

Recalls / Class II

Class IID-0418-2023

Product

Vigabatrin for Oral Solution, USP, 500 mg, Rx Only, 50-packets/carton, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703 Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, INDIA. Packet NDC 16729-521-63, UPC 3 16729 52163 5; Carton NDC 16729-521-11, UPC 3 16729 52111 6.

Affected lot / code info
Batches: R2100308, Exp. Date 2/28/2023

Why it was recalled

CGMP Deviations: recalling drug products following an FDA inspection.

Recalling firm

Firm
Accord Healthcare, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
1009 Slater Rd Ste 210B, N/A, Durham, North Carolina 27703-8446

Distribution

Quantity
821 cartons
Distribution pattern
United States including Puerto Rico and Canada

Timeline

Recall initiated
2023-02-07
FDA classified
2023-03-02
Posted by FDA
2023-03-08
Terminated
2024-04-22
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0418-2023. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls